Professor and Chair, Department of Urologic Surgery Hamilton and Howd Chair in Urologic Oncology Co-Director, Vanderbilt Center for Surgical Quality and Outcomes Research
Urology
Dr. David F. Penson, MD
|
|
Give Review
Dr. David F. Penson is an expert in the field of Urology. He went to medical school at Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification" and "Fellow (FACS)". David Penson is also published. He has 85 publications published. The lastest publication: "Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice.' He accepts Medicare.
Publications
- Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
- The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
- Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.
- The Pendulum of Prostate Cancer Screening.
- Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice.
- Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality.
- Prostate Cancer survivorship care guideline: american society of clinical oncology clinical practice guideline endorsement.
- Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
- Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries.
- Bone complications among prostate Cancer survivors: long-term follow-up from the prostate Cancer outcomes study.
- Knowledge of the harms of tobacco use among patients with Bladder cancer.
- Nationwide Trends in Mastectomy for Early-Stage Breast Cancer.
- Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
- Influence of Age on Incident Diabetes and Cardiovascular Disease Among Prostate Cancer Survivors Receiving Androgen Deprivation Therapy.
- Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
- The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
- Trends in urodynamics in U.S. female medicare beneficiaries, 2000-2010.
- The effect of health insurance status on the treatment and outcomes of patients with colorectal Cancer.
- Trends in the use of evidence-based therapy for resectable gastric Cancer.
- The Politics of Prostate Cancer Screening.
- Assessment of Patient Experience With Unilateral Vocal Fold Immobility: A Preliminary Study.
- Twitter Response to the United States Preventive Services Task Force Recommendations against Screening with Prostate Specific Antigen.
- Urinary functional outcomes in female neoBladder patients.
- Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate Cancer treatment.
- Epidemiology of Vocal Fold Paralyses after Total Thyroidectomy for Well-Differentiated Thyroid Cancer in a Medicare Population.
- Overdiagnosis and Overtreatment of Prostate Cancer.
- Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.
- Racial variation in the quality of surgical care for Bladder cancer.
- Capsule commentary on Shahinian et al.: Patterns of bone mineral density testing in men receiving androgen deprivation for prostate Cancer.
- Comparative effectiveness research in localized prostate Cancer treatment.
- Trends in the Multimodality Treatment of Resectable Colorectal Liver Metastases: an Underutilized Strategy.
- Impact of Prostate Cancer on Sexual Relationships: A Longitudinal Perspective on Intimate Partners' Experiences.
- Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis.
- Quality of Life After Sipuleucel-T Therapy: Results From a Randomized, Double-blind Study in Patients With Androgen-dependent Prostate Cancer.
- Burden among partner caregivers of patients diagnosed with localized prostate Cancer within 1 year after diagnosis: an economic perspective.
- Time to raise the bar in localised prostate Cancer.
- Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.
- Effectiveness of hormonal and surgical therapies for cryptorchidism: a systematic review.
- Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysis.
- Patterns and predictors of urodynamics use in the United States.
- Urinary functional outcome following radical cystoprostatectomy and ileal neoBladder reconstruction in male patients.
- Castration-Resistant Prostate Cancer: AUA Guideline.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate Cancer.
- Early Detection of Prostate Cancer: AUA Guideline.
- Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer.
- Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries.
- Association between race and follow-up diagnostic care after a positive prostate Cancer screening test in the Prostate, Lung, Colorectal, and Ovarian Cancer screening ...
- Post-Prostatectomy Incontinence and Pelvic Floor Muscle Training: A Defining Problem.
- Ureteroenteric anastomotic Strictures after radical cystectomy-does operative approach matter?
- Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling, and Specimen Processing.
- Centralization of radical Prostatectomy in the United States.
- Factors associated with satisfaction with prostate Cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
- Salvage robotic assisted laparoscopic radical Prostatectomy: a single institution, 5-year experience.
- Long-term functional outcomes after treatment for localized prostate Cancer.
- The prostate Cancer conundrum revisited: treatment changes and prostate Cancer mortality declines.
- Volume outcomes of cystectomy--is it the surgeon or the setting?
- Factors influencing patients' acceptance and adherence to active surveillance.
- The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnose...
- Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
- Comparison of open live donor nephrectomy, laparoscopic live donor nephrectomy, and hand-assisted live donor nephrectomy: A cost-minimization analysis.
- The patient protection and affordable care act: The impact on urologic Cancer care.
- Systemic therapy and the urologic oncologist: A unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient.
- Re: US Physician Practices Versus Canadians: Spending Nearly Four Times as Much Money Interacting With Payers.
- Re: Higher Fees Paid to US Physicians Drive Higher Spending for Physician Services Compared to Other Countries.
- Re: Today's 'Meaningful Use' Standard for Medication Orders by Hospitals may Save Few Lives; Later Stages may do More.
- Obesity, body composition, and prostate Cancer.
- National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.
- Re: fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data.
- Re: satisfaction profiles in men using intracavernosal injection therapy.
- Re: retropubic versus transobturator midUrethral slings for stress incontinence.
- The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate Cancer in the medicare population.
- Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate Cancer.
- Re: Assessment of Quality of Cancer-Related Follow-Up Care From the Cancer Survivor's Perspective.
- Re: validating the patient safety indicators in the veterans health administration: are they ready for prime time?
- Re: readmissions in the postoperative period following Urinary diversion.
- Re: Patient Preferences and Urologist Recommendations Among Local-Stage Prostate Cancer Patients who Present for Initial Consultation and Second Opinions.
- Re: overtreatment of men with low-risk prostate Cancer and significant comorbidity.
- Re: Managing Localized Prostate Cancer by Radical Prostatectomy or Watchful Waiting: Cost Analysis of a Randomized Trial (SPCG-4).
- Re: do men make informed decisions about prostate Cancer screening? Baseline results from the "take the wheel" trial.
- Socioeconomic factors, urological epidemiology and practice patterns.
- The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for Bladder cancer.
- Predicting the probability of 90-day survival of elderly patients with Bladder cancer treated with radical cystectomy.
- Epidemiology of Stress Urinary Incontinence in Women.
Schools
Boston University School Of Medicine
UCLA Mc
Yale University
Procedures Preformed
- Adrenalectomy
- Cystotomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
UCLA Medical Center -
Boston University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1164457867 | |
| NPPES Provider LastName | PENSON | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 372322765 | |
| NPPES Provider State | TN | |
| Specialty Description | General Surgery | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164457867 |
| Last Name Of The Provider | PENSON |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Claude H. Workman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith W. Hagan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sam S. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Tudor Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Schull, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark D. Flora, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Whitson Lowe Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Douglas C. Altenbern, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth A. Drzewiecki, MD |
|
Dr. Corinne L. Puzio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shreyas S. Joshi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dominic H. Tang, MD
This Doctor is OpenDoctor Recommended.
|